<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>6412071</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">30642760</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">6412071</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">S2213-1582(19)30004-X</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.1016/j.nicl.2019.101654</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">101654</article-id></all-ids><extracted-table><table-id>t0005</table-id><table-label>Table 1</table-label><table-caption>Sample characteristics.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" position="float" id="t0005"><label>Table 1</label><caption><p>Sample characteristics.</p></caption><alt-text id="al0025">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Characteristics</th><th colspan="2">CT (n = 18)<hr/></th><th colspan="2">Non-CT (<italic>n</italic> = 22)<hr/></th><th colspan="2">HC (n = 22)<hr/></th></tr><tr><th>n (%)</th><th>Mean (SD)</th><th>n (%)</th><th>Mean (SD)</th><th>n (%)</th><th>Mean (SD)</th></tr></thead><tbody><tr><td>Age (year)</td><td/><td>49.22 (11.13)</td><td/><td>53.82 (8.18)</td><td/><td>51.13 (8.79)</td></tr><tr><td>Education (year)</td><td/><td>15.17 (2.38)</td><td/><td>15.05 (2.15)</td><td/><td>16.54 (1.84)</td></tr><tr><td>Race<xref rid="tf0005" ref-type="table-fn">a</xref></td><td/><td/><td/><td/><td/><td/></tr><tr><td> White</td><td>14 (78)</td><td/><td>19 (86)</td><td/><td>20 (91)</td><td/></tr><tr><td> Non-white</td><td>4 (22)</td><td/><td>3 (14)</td><td/><td>2 (9)</td><td/></tr><tr><td>Stage</td><td/><td/><td/><td/><td/><td/></tr><tr><td> 0</td><td>0 (0)</td><td/><td>9 (41)</td><td/><td>–</td><td/></tr><tr><td> I</td><td>4 (22)</td><td/><td>11 (50)</td><td/><td>–</td><td/></tr><tr><td> II</td><td>10 (56)</td><td/><td>2 (9)</td><td/><td>–</td><td/></tr><tr><td> IIIa</td><td>4 (22)</td><td/><td>0 (0)</td><td/><td>–</td><td/></tr><tr><td>Hemoglobin (g/dl)</td><td/><td/><td/><td/><td/><td/></tr><tr><td> M0</td><td/><td>12.51 (0.72)</td><td/><td>13.63 (0.70)</td><td/><td>13.12 (0.92)</td></tr><tr><td> M5</td><td/><td>12.14 (0.89)</td><td/><td>13.17 (0.79)</td><td/><td>13.17 (0.84)</td></tr><tr><td> M12</td><td/><td>12.91 (0.75)</td><td/><td>13.70 (0.82)</td><td/><td>13.21 (1.08)</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: CT, chemotherapy-treated; non-CT, treated without chemotherapy; HC, healthy control; M0, baseline; M5, five-month follow-up; M12, twelve-month follow-up.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0005"><label>a</label><p id="np0005">85% Caucasian, 8% African American, 5% Asian American, 2% Native American.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Sample characteristics.</div>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Characteristics</th><th colspan="2">CT (n = 18)</th><th colspan="2">Non-CT (n = 22)</th><th colspan="2">HC (n = 22)</th></tr><tr><th>n (%)</th><th>Mean (SD)</th><th>n (%)</th><th>Mean (SD)</th><th>n (%)</th><th>Mean (SD)</th></tr></thead><tbody><tr><td>Age (year)</td><td/><td>49.22 (11.13)</td><td/><td>53.82 (8.18)</td><td/><td>51.13 (8.79)</td></tr><tr><td>Education (year)</td><td/><td>15.17 (2.38)</td><td/><td>15.05 (2.15)</td><td/><td>16.54 (1.84)</td></tr><tr><td>Race???</td><td/><td/><td/><td/><td/><td/></tr><tr><td> White</td><td>14 (78)</td><td/><td>19 (86)</td><td/><td>20 (91)</td><td/></tr><tr><td> Non-white</td><td>4 (22)</td><td/><td>3 (14)</td><td/><td>2 (9)</td><td/></tr><tr><td>Stage</td><td/><td/><td/><td/><td/><td/></tr><tr><td> 0</td><td>0 (0)</td><td/><td>9 (41)</td><td/><td>–</td><td/></tr><tr><td> I</td><td>4 (22)</td><td/><td>11 (50)</td><td/><td>–</td><td/></tr><tr><td> II</td><td>10 (56)</td><td/><td>2 (9)</td><td/><td>–</td><td/></tr><tr><td> IIIa</td><td>4 (22)</td><td/><td>0 (0)</td><td/><td>–</td><td/></tr><tr><td>Hemoglobin (g/dl)</td><td/><td/><td/><td/><td/><td/></tr><tr><td> M0</td><td/><td>12.51 (0.72)</td><td/><td>13.63 (0.70)</td><td/><td>13.12 (0.92)</td></tr><tr><td> M5</td><td/><td>12.14 (0.89)</td><td/><td>13.17 (0.79)</td><td/><td>13.17 (0.84)</td></tr><tr><td> M12</td><td/><td>12.91 (0.75)</td><td/><td>13.70 (0.82)</td><td/><td>13.21 (1.08)</td></tr></tbody></table></div>Abbreviations: CT, chemotherapy-treated; non-CT, treated without chemotherapy; HC, healthy control; M0, baseline; M5, five-month follow-up; M12, twelve-month follow-up.a85% Caucasian, 8% African American, 5% Asian American, 2% Native American.</transformed-table></extracted-table></extracted-tables-set>